Pregnancy News and Research

Latest Pregnancy News and Research

EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC

Eli Lilly and Company announced today that the European Commission has granted approval for the use of ALIMTA (pemetrexed for injection) as a single agent for continuation maintenance therapy in patients with a particular type of lung cancer, called advanced nonsquamous non-small cell lung cancer

29 Oct 2011

UCLA professor to receive ATA's Sidney H. Ingbar Distinguished Lectureship Award

The American Thyroid Association's (ATA) Sidney H. Ingbar Distinguished Lectureship Award recognizes outstanding academic achievements in thyroidology. An honorarium is conferred each year at the ATA Annual Meeting to an established investigator who has made major contributions to thyroid-related research over many years.

28 Oct 2011

Impact of pelvic inflammatory disease on teen girls underestimated

A Johns Hopkins Children's Center study comparing perceptions of pelvic inflammatory disease (PID) among teen girls and parents has found that parents seriously underestimate the emotional and medical impact this sexually transmitted disease has on teenagers.

28 Oct 2011

Longer looks: Looking for the inventor of the individual mandate, Miss. abortion referendum may have wider effects

In the course of defending the health care bill he passed in Massachusetts, Mitt Romney told Newt Gingrich that he got the idea for the individual mandate -- a rule dictating that everyone must buy health insurance or pay a penalty -- from the Heritage Foundation, a conservative Washington, D.C. think tank. Is it really responsible for creating the policy that is now so anathema to conservatives?

28 Oct 2011

Study reveals smaller teeth in premature children

The size of teeth in premature children is smaller. This has been established in a study from the Faculty of Odontology at Malmö University in Sweden.

28 Oct 2011

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Bristol-Myers Squibb Company and Gilead Sciences, Inc. today announced a licensing agreement for Bristol-Myers Squibb to develop and commercialize a fixed-dose combination containing Bristol-Myers Squibb's protease inhibitor REYATAZ (atazanavir sulfate) and Gilead's cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain HIV medicines to potentially allow for one pill once daily dosing.

27 Oct 2011

Late pregnancy snoring could harm mother and baby alike

Nearly half of pregnant women may develop snoring by their final trimester and this could lead to dangerous health problems for mother and baby, Australian sleep researchers have shown. According to professor of medicine, Colin Sullivan, research found woman who started snoring during the later stages of pregnancy were at increased risk of developing high blood pressure.

27 Oct 2011

Al Jazeera examines maternal mortality in Afghanistan

Al Jazeera examines maternal mortality in Afghanistan, which "remains one of the worst places to be a mother," 10 years after the beginning of the U.S. war in Afghanistan and "despite billions of dollars in aid and considerable progress." In an accompanying video, the news service reports, "One in five children born in Afghanistan dies by the age of five, and the statistics for mothers aren't good either."

27 Oct 2011

Computer-delivered intervention for pregnant women at risk for alcohol use

A team of researchers at Wayne State University's Parent Health Lab in the School of Medicine have received a three-year grant to develop a computer-delivered intervention for pregnant women at risk for alcohol use, which can lead to lifelong negative effects on the fetus.

27 Oct 2011

Study provides details on genetics behind many metabolic diseases

In what is so far the largest investigation of its kind, researchers uncovered a wide range of new insights about common diseases and how they are affected by differences between two persons' genes. The results from this study could lead to highly targeted, individualized therapies.

27 Oct 2011

Opinion pieces respond to U.N. special rapporteur's report on reproductive health policies

Several opinion pieces respond to a report presented on Monday to the U.N. General Assembly by Arnand Grover, U.N. special rapporteur for the Right to Health, that "considers the impact of criminal and other legal restrictions on abortion; conduct during pregnancy; contraception and family planning; and the provision of sexual and reproductive education and information," according to the report summary.

27 Oct 2011

Taking the Pill for 10 years can reduce risk of ovarian cancer by almost half

Taking the Pill for 10 years can reduce the risk of ovarian cancer by almost half (45 per cent), new research part-funded by Cancer Research UK shows today.

27 Oct 2011

One embryo is all it takes for a successful IVF: Study

Doctors practicing IVF often transferred multiple embryos to a woman’s body at once, in the hope that at least one of them would lead to a successful pregnancy. That changes now as a new study from researchers at the University of Iowa in Iowa City found that women who had only one embryo transferred during IVF didn’t have lower chances of getting pregnant, but they did have a lower risk of giving birth to twins than women who had multiple embryos transferred.

25 Oct 2011

BPA exposure in mothers may affect unborn daughters’ behavior: Study

A new federal study revealed Monday in the journal Pediatrics shows that bisphenol A (BPA) - a chemical used widely in plastic bottles, metal cans and other consumer products could be linked to behavioral and emotional problems in toddler girls.

25 Oct 2011

Challenging the view that the world's growing population represents power, prosperity

As the world's population approaches seven billion, Joel Cohen, a mathematical biologist and the head of the Laboratory of Populations at Rockefeller University and Columbia University, examines the implications of "the enormous increases in households, cities, material consumption and waste" on health, agriculture, water security, the environment and poverty in this New York Times opinion piece.

24 Oct 2011

Blood tests and cultures may not be necessary in detecting early-onset GBS in newborns

For newborn infants at risk of infection with group B streptococcal (GBS) bacteria, screening blood tests cause extra pain and anxiety—without increasing detection of early-onset GBS disease, reports a study in the October issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

24 Oct 2011

SafeMinds praises UNEP's draft treaty ban on use of mercury in pharma products

SafeMinds applauds UNEP's draft treaty language which does not exempt the use of mercury in pharmaceutical products, including vaccines, from the global ban. Governmental regulators, public health officials and pharmaceutical companies have recognized that the toxicity of mercury in pharmaceutical and personal care products, to which people are directly exposed, justifies a preventive approach to minimize all exposures.

24 Oct 2011

Gestational BPA exposure associated with behavior, emotional problems in young girls

Exposure in the womb to bisphenol A (BPA) - a chemical used to make plastic containers and other consumer goods - is associated with behavior and emotional problems in young girls, according to a study led by researchers at Harvard School of Public Health (HSPH), Cincinnati Children's Hospital and Medical Center, and Simon Fraser University in Vancouver, British Columbia.

24 Oct 2011

Janssen announces FDA label update approval for PREZISTA HIV tablets

Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a label update for PREZISTA (darunavir) tablets to include 192-week data from the ARTEMIS study.

22 Oct 2011

Viewpoints: The toll of Medicare fraud; insurer's Medicare Advantage switch can confuse seniors

In a searing two-part investigative series earlier this week, the Chronicle's Terri Langford wrote about unscrupulous operators, here in Houston, who make millions of Medicare dollars exploiting the most vulnerable of our local residents through private ambulances and for-profit psychiatric clinics. Medicare, and American taxpayers, are footing the bill, which is enormous.

22 Oct 2011

Pregnancy News and Research

Latest Pregnancy News and Research

EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC

UCLA professor to receive ATA's Sidney H. Ingbar Distinguished Lectureship Award

Impact of pelvic inflammatory disease on teen girls underestimated

Longer looks: Looking for the inventor of the individual mandate, Miss. abortion referendum may have wider effects

Study reveals smaller teeth in premature children

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Late pregnancy snoring could harm mother and baby alike

Al Jazeera examines maternal mortality in Afghanistan

Computer-delivered intervention for pregnant women at risk for alcohol use

Study provides details on genetics behind many metabolic diseases

Opinion pieces respond to U.N. special rapporteur's report on reproductive health policies

Taking the Pill for 10 years can reduce risk of ovarian cancer by almost half

One embryo is all it takes for a successful IVF: Study

BPA exposure in mothers may affect unborn daughters’ behavior: Study

Challenging the view that the world's growing population represents power, prosperity

Blood tests and cultures may not be necessary in detecting early-onset GBS in newborns

SafeMinds praises UNEP's draft treaty ban on use of mercury in pharma products

Gestational BPA exposure associated with behavior, emotional problems in young girls

Janssen announces FDA label update approval for PREZISTA HIV tablets

Viewpoints: The toll of Medicare fraud; insurer's Medicare Advantage switch can confuse seniors

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pregnancy News and Research

Latest Pregnancy News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in